… , nanoparticles emerge as a powerful and promising strategy for disease prevention and
management by delivering drugs in the optimal dose … , for instance, the characterisation of early …

… was made to synthesize, characterize, and develop many … , HA nanoparticles/polymeric poly
lactide-co-glycolide (PLGA) … In this experiment, our goal is to find the optimal concentration …

… Recent efforts in improving the efficiency of nanoparticle synthesis and exploring their
biomedical applications will hopefully lead to the implementation of these approaches on a large …

… In this review, the detailed study of the transferosomes loaded topical preparations with
anticancer drugs like 5fluorouracil,cisplatin etc and to characterize the parameters like drug …

… This study aimed to develop and characterize lipid-core nanocapsules (LNC) containing SV
(SV-LNC) or LV (LV-LNC), evaluating the effects of SV-LNC in an animal model of cognitive …

… Design-Expert software was used to perform various RSM computations for the current
optimization analysis (version 11.0.0.0). Using a multiple linear regression analysis technique, a …

… Materials and Methods: Box-Behnken Design (BBD) was used for optimizing the
nanoparticles. Eudragit was used in the preparations in varying concentrations (1-2% w/v). The …

… Therefore, we suggest a combination of nanotechnology with fluorinated molecules can
be a promising/potential therapeutic treatment to meet the desired pharmacokinetic/…

… Herein, we have described the main characteristics and methods of the application of … of
PLGA synergistically increased nanoparticle uptake by glioblastoma cells (Table 2). The optimal …

Non-viral gene therapy of the brain is enabled by the development of plasmid DNA brain
delivery technology, which requires the engineering and manufacturing of nanomedicines that …